Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $775.01 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $150.99 | 10 | $0 (2022) |
| Lilly USA, LLC | $101.19 | 6 | $0 (2022) |
| Novo Nordisk Inc | $81.52 | 5 | $0 (2023) |
| Endo Pharmaceuticals Inc. | $72.30 | 3 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $55.95 | 3 | $0 (2017) |
| SANOFI PASTEUR INC. | $38.46 | 2 | $0 (2017) |
| SANOFI-AVENTIS U.S. LLC | $37.57 | 3 | $0 (2017) |
| Amgen Inc. | $30.36 | 2 | $0 (2019) |
| PFIZER INC. | $25.75 | 2 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $25.12 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $25.12 | 1 | Otsuka America Pharmaceutical, Inc. ($25.12) |
| 2023 | $24.16 | 1 | Novo Nordisk Inc ($24.16) |
| 2022 | $27.66 | 2 | Lilly USA, LLC ($15.08) |
| 2019 | $40.55 | 2 | Endo Pharmaceuticals Inc. ($24.05) |
| 2018 | $110.38 | 6 | Endo Pharmaceuticals Inc. ($48.25) |
| 2017 | $547.14 | 36 | AstraZeneca Pharmaceuticals LP ($138.41) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/08/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.12 | General |
| Category: PSYCHIATRY | ||||||
| 03/01/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: Diabetes | ||||||
| 11/17/2022 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: Diabetes | ||||||
| 10/26/2022 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Respiratory | ||||||
| 09/16/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Bone Health | ||||||
| 03/19/2019 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 10/31/2018 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $23.85 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 09/24/2018 | Endo Pharmaceuticals Inc. | NASCOBAL (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: PRESCRIPTION SUPPLEMENT | ||||||
| 08/27/2018 | AbbVie, Inc. | Humira (Biological) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Immunology | ||||||
| 07/11/2018 | Ironwood Pharmaceuticals, Inc | LINZESS (Drug), VIBERZI, DUZALLO | Food and Beverage | In-kind items and services | $15.32 | General |
| Category: Gastroenterology | ||||||
| 03/12/2018 | Novo Nordisk Inc | Victoza (Drug), Tresiba, Xultophy 100/3.6 | Food and Beverage | In-kind items and services | $16.89 | General |
| Category: Diabetes | ||||||
| 02/12/2018 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $17.49 | General |
| Category: UROLOGY | ||||||
| 09/29/2017 | PFIZER INC. | VIAGRA (Drug), CHANTIX, ELIQUIS | Food and Beverage | In-kind items and services | $12.76 | General |
| Category: GENITOURINARY (SEXUAL HEALTH);CARDIOVASCULAR;RESPIRATORY | ||||||
| 07/24/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $12.92 | General |
| Category: Respiratory | ||||||
| 07/10/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: Diabetes | ||||||
| 06/26/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.30 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/22/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, TRADJENTA | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: DIABETES | ||||||
| 06/21/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $14.72 | General |
| Category: Diabetes | ||||||
| 06/20/2017 | Merck Sharp & Dohme Corporation | JANUMET (Drug), ZOSTAVAX | Food and Beverage | In-kind items and services | $10.70 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/13/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: DIABETES | ||||||
| 06/12/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/05/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Respiratory | ||||||
| 05/24/2017 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: DIABETES | ||||||
| 05/17/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI, TRADJENTA | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: DIABETES | ||||||
| 05/16/2017 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 102 | 131 | $16,729 | $6,431 |
| 2022 | 3 | 59 | 82 | $12,085 | $4,554 |
| 2021 | 4 | 73 | 118 | $17,549 | $6,531 |
| 2020 | 4 | 112 | 114 | $21,163 | $6,746 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 31 | $7,099 | $2,527 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 13 | 13 | $2,977 | $1,734 | 58.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 29 | $4,553 | $1,639 | 36.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 21 | 29 | $580.00 | $243.60 | 42.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 12 | 14 | $770.00 | $144.90 | 18.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 12 | 15 | $750.00 | $142.80 | 19.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 29 | $6,641 | $2,676 | 40.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 32 | $5,024 | $1,816 | 36.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 15 | 21 | $420.00 | $62.13 | 14.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 33 | $7,557 | $2,921 | 38.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 31 | 36 | $5,652 | $2,599 | 46.0% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2021 | 12 | 12 | $3,600 | $900.00 | 25.0% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 13 | 37 | $740.00 | $111.00 | 15.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 49 | 50 | $7,850 | $2,623 | 33.4% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2020 | 23 | 23 | $6,900 | $2,300 | 33.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 25 | $5,725 | $1,522 | 26.6% |
| 99211 | Established patient office or other outpatient visit, typically 5 minutes | Office | 2020 | 16 | 16 | $688.00 | $300.75 | 43.7% |
About Dr. Nosheen Syed, M.D
Dr. Nosheen Syed, M.D is a Family Medicine healthcare provider based in Bloomingdale, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/27/2012. The National Provider Identifier (NPI) number assigned to this provider is 1386908002.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nosheen Syed, M.D has received a total of $775.01 in payments from pharmaceutical and medical device companies, with $25.12 received in 2024. These payments were reported across 48 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($775.01).
As a Medicare-enrolled provider, Syed has provided services to 346 Medicare beneficiaries, totaling 445 services with total Medicare billing of $24,261. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine
- Location Bloomingdale, IL
- Active Since 06/27/2012
- Last Updated 08/23/2023
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1386908002
Products in Payments
- NASCOBAL (Drug) $72.30
- SYMBICORT (Drug) $69.90
- TRULICITY (Drug) $66.05
- JARDIANCE (Drug) $49.59
- SOLIQUA (Drug) $37.57
- FARXIGA (Drug) $35.86
- BEVESPI AEROSPHERE (Drug) $32.65
- Victoza (Drug) $27.26
- REXULTI (Drug) $25.12
- Ozempic (Drug) $24.16
- XIFAXAN (Drug) $23.30
- Trintellix (Drug) $22.42
- STIOLTO (Drug) $21.44
- FLUZONE HIGH-DOSE (Drug) $20.22
- BASAGLAR (Drug) $20.06
- Saxenda (Drug) $18.64
- VYVANSE (Drug) $18.26
- PENTACEL (Drug) $18.24
- MYRBETRIQ (Drug) $17.49
- EVENITY (Biological) $16.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bloomingdale
Dr. Imelda Sia, Md, MD
Family Medicine — Payments: $18,873
Dr. David De Ramos, Do, DO
Family Medicine — Payments: $4,180
Dr. Iulia O'neill, Md, MD
Family Medicine — Payments: $3,284
Dr. Charity Alikpala, D.o, D.O
Family Medicine — Payments: $2,677
Dr. Richard Pinney, Md, MD
Family Medicine — Payments: $2,292
Dr. Maricruz Pajares, Md, MD
Family Medicine — Payments: $1,620